Invention Publication
- Patent Title: ANTIBODIES AGAINST INFLUENZA A VIRUSES
-
Application No.: US18253383Application Date: 2021-11-19
-
Publication No.: US20240317841A1Publication Date: 2024-09-26
- Inventor: Davide CORTI , Matteo Samuele PIZZUTO , Fabrizia ZATTA , Elisabetta CAMERONI , Gyorgy SNELL
- Applicant: Vir Biotechnology, Inc. , Humabs BioMed SA
- Applicant Address: US CA San Francisco
- Assignee: Vir Biotechnology, Inc.,Humabs BioMed SA
- Current Assignee: Vir Biotechnology, Inc.,Humabs BioMed SA
- Current Assignee Address: US CA San Francisco
- International Application: PCT/US2021/060123 2021.11.19
- Date entered country: 2023-05-17
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/00 ; A61P31/16

Abstract:
The instant disclosure provides antibodies and antigen-binding fragments thereof that can bind to an influenza A virus hemagglutinin (HA) and can neutralize a IAV infection. Also provided are polynucleotides that encode an antibody or antigen-binding fragment, vectors that comprise such polynucleotides, host cells that can express the antibodies or antigen-binding fragments, related compositions, and methods of using the herein disclosed compositions to, for example, treat or prevent an IAV infection.
Information query